A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry

Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects. Resistance to these inhibitors emerges rapidly in the clinic, suggesting that successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Baldick, Carl J., Wichroski, Michael J., Pendri, Annapurna, Walsh, Ann W., Fang, Jie, Mazzucco, Charles E., Pokornowski, Kevin A., Rose, Ronald E., Eggers, Betsy J., Hsu, Mayla, Zhai, Weixu, Zhai, Guangzhi, Gerritz, Samuel W., Poss, Michael A., Meanwell, Nicholas A., Cockett, Mark I., Tenney, Daniel J.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936744/
https://www.ncbi.nlm.nih.gov/pubmed/20838466
http://dx.doi.org/10.1371/journal.ppat.1001086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936744/
https://www.ncbi.nlm.nih.gov/pubmed/20838466
http://dx.doi.org/10.1371/journal.ppat.1001086

Ejemplares similares